Showing results (41-50 of 179) with videos related to
Sort By:
Pageof 18
Journal of Pediatric Surgery|March 1, 1988
Cholelithiasis in childhood: a follow-up studyJ F Robertson, R Carachi, E M Sweet, et al.Anti-Cancer Drugs|May 2, 2000
New calmodulin antagonists inhibit in vitro growth of human breast cancer cell lines independent of their estrogen receptor statusE Jacobs, P C Bulpitt, I G Coutts, et al.Anticancer Research|July 1, 1995
Serum tissue polypeptide specific antigen (TPS) in breast cancer patients: comparison with CA 15.3 and CEAP C Willsher, J Beaver, R W Blamey, et al.British Journal of Cancer|July 1, 1995
Potential for cost economies in guiding therapy in patients with metastatic breast cancerJ F Robertson, D K Whynes, A Dixon, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1997
Audit of a conservative management policy of the axilla in elderly patients with operable breast cancerM al-Hilaly, P C Willsher, J F Robertson, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-upJ F Robertson, I O Ellis, C W Elston, et al.Hormone Research|January 1, 1989
Zoladex in advanced breast cancerJ F Robertson, R I Nicholson, K J Walker, et al.International Journal of Cancer|June 16, 2001
Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancerJ M Gee, J F Robertson, I O Ellis, et al.Gut|August 1, 1993
Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidineS A Watson, L J Wilkinson, J F Robertson, et al.The International Journal of Biological Markers|January 1, 1996
Oestrogen and progesterone receptors as prognostic variables in hormonally treated breast cancerJ F Robertson, P M Cannon, R I Nicholson, et al.Pageof 18